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DIETARTY EDUCATOIN IN TYPE 1 DIABETES EDUCATION (DAFNE) AND
ALBUMINURIA CHANGE: KUWAIT’S EXPERIENCE
Ebaa Al Ozairi, Juama Alkandari, Etab Tagadhom, Reem Asad
Dasman Diabetes Institute, Dasman, Kuwait
The Dose Adjustment for Normal Eating (DAFNE) course is a structured
education program that aims to teach type 1 diabetes to change their self
care behaviors by estimating the carbohydrate content of food and
adjusting their insulin doses accordingly in order to maintain metabolic
control. Microalbuminura is well known to increase morbidity and
mortality. DAFNE has been found to improve the gylcosylated haemoglobin
but no dietician education porga has been shown to be effective on
albuminurea. Our aim of this study was to investigate the effect of a DAFNE
course on regression of albuminurea. Seventy two type 1 patients have
completed DAFNE course in Kuwait led by dieticians. Twenty eight
participants were positive for albuminuria prior to DAFNE Course.
Carbohydrate counting skills resulted in improvement of HbA1c. Twnety
participants had regression in their albuminuria without blood pressure
intervention.
In conclusion, this study shows signiﬁcantly improvement in
albuminurea with sustained improvement in HbA1c through better
carbohydrate skills. DAFNE course should prove cost effective with
sustained glycemic proﬁle and improvement of albuminuria and should
become more widely available.
http://dx.doi.org/10.1016/j.krcp.2012.04.325
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EFFECT OF LOW-DOSE NIACIN ON DYSLIPIDEMIA, SERUM PHOSPHORUS
LEVELS AND ADVERSE EFFECTS IN PATIENTS WITH CHRONIC
KIDNEY DISEASE
Won Suk An, Hyo Jin Kang, Ki Hyun Kim
Seong Eun Kim, Young Ki Son. Department of internal medicine, Dong-A
university, Busan, Republic of Korea
Niacin supplementation improves dyslipidemia and lowers serum
phosphorus levels in chronic kidney disease (CKD) patients. However, its
adverse effects, including hot ﬂusing, hinder the administration of niacin.
We evaluated whether low-dose niacin supplementation can improve
dyslipidemia, lower serum phosphorus levels, and be administered with a
low frequency of adverse effects in patients with CKD. We retrospectively
analyzed the clinical records of CKD patients who had taken niacin from
January, 2009 to June, 2011. We excluded patients with CKD1 and CKD 5.
We then enrolled 31 CKD patients who had taken niacin at a ﬁxed-dose of
500mg/day for 6 months. We also randomly selected 30 CKD patients who
had been taking statin for 9 months as a control group. Among 34 CKD
patients prescribed niacin, 5 patients (14%) complained of adverse effects,
and 3 CKD patients (8%) discontinued niacin. There were no signiﬁcant
differences in baseline data between the niacin group and the control
group. The proportion of patients in the niacin group who had been taking
a statin, or omega-3 fatty acids was 67.7% and 48.8%, respectively. In the
niacin group, high density lipoprotein cholesterol (HDL) levels was
signiﬁcantly increased (po0.05), and triglyceride (po0.05) at 12 weeks
and 24 weeks compared to baseline levels. In the niacin group,
phosphorous levels (po0.05) were signiﬁcantly decreased, and glomerular
ﬁltration rate (GFR) was signiﬁcantly increased (p¼0.016) at 24 weeks
compared to baseline values; however, serum creatinine levels did not
signiﬁcantly change. Low dose niacin (500 mg/day) had a low freqeuncy of
adverse effects and also improved dyslipidemia, lowered serum
phosphorus levels, and increased GFR in CKD patients. Further studies are
needed to evaluate the long term effects of low-dose niacin for renal
progression of CKD.
http://dx.doi.org/10.1016/j.krcp.2012.04.326
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VASCULAR CALCIFICATION ON PLAIN RADIOGRAPHS IS ASSOCIATED
WITH CAROTID INTIMA MEDIA THICKNESS, MALNUTRITION AND
CARDIOVASCULAR EVENTS IN DIALYSIS PATIENTS
Won Suk An 2, Ki Hyun Kim2, Seong Eun Kim 2, Young Ki Son 2,
Joong Kyung Kim1
1 Department of internal medicine, Dong-A university, Bong Seng Hospital,
2 Busan, Republic of Korea
Vascular calciﬁcation (VC) and carotid intima media thickness (CIMT) are
highly correlated with cardiovascular (CV) disease. We hypothesized that
signiﬁcant VC on plain radiographs is associated with CIMT and CV events
in dialysis patietns. In addition, we evaluated risk factors for VC
progression on plain radiographs in dialysis patietns. In this two-year
observational, prospective study, 67 dialysis patients were included. We
checked plain radiographs at baseline and after 2 years. Laboratory tests
and malnutrition score were obtained at baseline, after 1 year, and after
2 years. The mean age of dialysis patients was 56.3 7 10.3 years and the
duration of dialysis was 41.3 7 34.5 months. The prevalence of signiﬁcant
VC was 61.2% and the prevalence of carotid artery atheromatous plaque
was 36.6% in enrolled dialysis patients. The prevalence of carotid artery
atheromatous plaque (p¼ 0.025), CIMT (right: p¼ 0.045, left: p¼ 0.014),
malnutrition scores and CRP were signiﬁcantly higher in patients with
signiﬁcant VC compared to patients without signiﬁcant VC. Serum albumin
and total iron binding capacity were signiﬁcantly lower in patients with
signiﬁcant VC compared to patients without signiﬁcant VC. During an
mean observational period of 22 months there were 6 CV deaths and 17
patients suffered from CV events. Patients without signiﬁcant VC showed
lower CV events by the Kaplan-Meier method (p¼ 0.015). VC progression
on plain radiographs was found in 35.7% among 56 patients followed up.
Hemoglobin (Hb) was signiﬁcantly increased according to elapsed time in
patients who did not show VC progression on plain radiographs (10.3 g/dL
at baseline, 10.8 g/dL after 1 year, 11.4 g/dL after 2 years). Hb
(beta¼0.458, p¼ 0.006) after 2 years was an independent factor for VC
progression on plain radiographs. In conclusion, signiﬁcant VC on plain
radiographs was associated with CIMT, malnutrition, inﬂammation and CV
events in dialysis patients. Conditions maintaining adaquate Hb maybe
retard VC progression on plain radiographs in dialysis patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.327
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DIFFERENT ACUTE METABOLISM OF FRUCTOSE IN DIALYSIS PATIENTS
COMPARED TO HEALTHY SUBJECTS
Bjorn Anderstam, Ann-Christin Bragfors-Helin, Jonas Axelsson,
Abdul Rashid Qureshi, Rolf Wibom, Bengt Lindholm, Peter Stenvinkel
Renal Medicin & Baxter Novum, Clintec, Karolinska Institutet, Stockholm,
Sweden.
The consumption of fructose has increased dramatically during the last
two decades and parallels the epidemics of obesity, metabolic syndrome,
diabetes and chronic kidney disease ADDIN EN.CITE ADDIN EN.CITE.DATA .
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